Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Determinants of eye drop size.

Luc Van Santvliet1, Annick Ludwig

  • 1University of Antwerp (U.I.A.), Laboratory of Pharmaceutical Technology and Biopharmacy, Antwerp, Belgium.

Survey of Ophthalmology
|March 5, 2004
PubMed
Summary

This review discusses optimizing ophthalmic solutions for eye drop delivery. It explores reducing drop volume for better biopharmaceutical and economic outcomes, enhancing patient administration techniques.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimisation of HPMC ophthalmic inserts with sustained release properties as a carrier for thermolabile therapeutics.

International journal of pharmaceutics·2017
Same author

Evaluation of a newly developed HPMC ophthalmic insert with sustained release properties as a carrier for thermolabile therapeutics.

International journal of pharmaceutics·2015
Same author

Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A.

International journal of pharmaceutics·2014
Same author

Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2012
Same author

The effect of HPβCD on Cyclosporine A in-vitro release from PLGA nanoparticles.

Journal of controlled release : official journal of the Controlled Release Society·2011
Same author

Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.

Journal of controlled release : official journal of the Controlled Release Society·2011

Area of Science:

  • Ophthalmology
  • Pharmaceutics
  • Biomedical Engineering

Background:

  • Ophthalmic solutions are commonly administered in eye drops ranging from 25 to 70 microliters.
  • Current delivery volumes are suboptimal from both biopharmaceutical and economic perspectives.
  • There is a need for smaller, more efficient eye drop volumes (5-15 microliters).

Purpose of the Study:

  • To review the technical, pharmaceutical, and therapeutic aspects of eye drop formation and delivery.
  • To discuss factors influencing eye drop size and patient instillation techniques.
  • To explore methods for improving eye drop administration, particularly for elderly patients.

Main Methods:

  • Review of existing literature on ophthalmic solution containers and delivery systems.
  • Analysis of determinants affecting eye drop volume, including container design and solution properties.
  • Examination of patient instillation techniques and assistive devices.

Main Results:

  • Eye drop volume is influenced by dropper tip design, bottle characteristics, solution properties, and patient technique.
  • Current delivery systems often yield larger drop volumes than therapeutically ideal.
  • Various instillation techniques and aids can improve administration efficacy.

Conclusions:

  • Optimizing eye drop volume is crucial for improved biopharmaceutical efficacy and cost-effectiveness.
  • Understanding the factors influencing drop size is key to developing better delivery systems.
  • Enhanced patient education and assistive devices can improve ophthalmic drug delivery outcomes, especially for vulnerable populations.

Related Experiment Videos